![Jeppe Ragnar Andersen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jeppe Ragnar Andersen
Vorstandsvorsitzender bei Sanos Group A/S
Profil
Jeppe Ragnar Andersen currently works at Sanos Group A, as Chief Executive Officer from 2020, Sonas BidCo ApS, as Chief Executive Officer, NBCD A, as Chief Executive Officer & Director, and Sonas Holdco ApS, as Chief Executive Officer from 2020.
Aktive Positionen von Jeppe Ragnar Andersen
Unternehmen | Position | Beginn |
---|---|---|
Sanos Group A/S
![]() Sanos Group A/S Pharmaceuticals: MajorHealth Technology Sanos Group A/S engages in the manufacture of pharmaceutical products. It also offers biotechnological research and experimental development services. The company was founded on June 3, 2020 and is headquartered in Herlev, Denmark. | Vorstandsvorsitzender | 03.06.2020 |
Sonas BidCo ApS
![]() Sonas BidCo ApS Finance/Rental/LeasingFinance Part of Muscles UK Holdings Ltd., Sonas BidCo ApS provides financial intermediation services. The company is based in Herlev, Denmark. The CEO of the Danish company is Jeppe Ragnar Andersen. | Vorstandsvorsitzender | - |
NBCD A/S
![]() NBCD A/S BiotechnologyHealth Technology NBCD A/S is based in Herlev, Denmark. Part of SIPCO Holdings Ltd., NBCD A/S is a contract research organization (CRO) dedicated to clinical drug development and research in osteoarthritis. The Danish company specializes in designing and executing clinical trials for both pain and disease-modifying osteoarthritis drugs (DMOAD) compounds. NBCD is known for their expertise in mitigating placebo response and designing osteoarthritis studies. The company supports biotech and pharmaceutical clients in advancing osteoarthritis compounds through all clinical development phases. With over 25 years of experience in osteoarthritis biomarkers and clinical trials, NBCD combines preclinical and clinical research to provide a faster and smarter evaluation of the potential clinical viability of drug candidates. The company was founded in 1989, and the CEO is Jeppe Ragnar Andersen. | Vorstandsvorsitzender | - |
Sonas Holdco ApS
![]() Sonas Holdco ApS Financial ConglomeratesFinance Sonas Holdco ApS functions as an investment holding Danish company. The private company is based in Soborg, Denmark and has subsidiaries in Denmark. The company was founded in 2020. Jeppe Ragnar Andersen has been the CEO of the company since 2020. | Vorstandsvorsitzender | 17.12.2020 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Sanos Group A/S
![]() Sanos Group A/S Pharmaceuticals: MajorHealth Technology Sanos Group A/S engages in the manufacture of pharmaceutical products. It also offers biotechnological research and experimental development services. The company was founded on June 3, 2020 and is headquartered in Herlev, Denmark. | Health Technology |
Sonas BidCo ApS
![]() Sonas BidCo ApS Finance/Rental/LeasingFinance Part of Muscles UK Holdings Ltd., Sonas BidCo ApS provides financial intermediation services. The company is based in Herlev, Denmark. The CEO of the Danish company is Jeppe Ragnar Andersen. | Finance |
NBCD A/S
![]() NBCD A/S BiotechnologyHealth Technology NBCD A/S is based in Herlev, Denmark. Part of SIPCO Holdings Ltd., NBCD A/S is a contract research organization (CRO) dedicated to clinical drug development and research in osteoarthritis. The Danish company specializes in designing and executing clinical trials for both pain and disease-modifying osteoarthritis drugs (DMOAD) compounds. NBCD is known for their expertise in mitigating placebo response and designing osteoarthritis studies. The company supports biotech and pharmaceutical clients in advancing osteoarthritis compounds through all clinical development phases. With over 25 years of experience in osteoarthritis biomarkers and clinical trials, NBCD combines preclinical and clinical research to provide a faster and smarter evaluation of the potential clinical viability of drug candidates. The company was founded in 1989, and the CEO is Jeppe Ragnar Andersen. | Health Technology |
Sonas Holdco ApS
![]() Sonas Holdco ApS Financial ConglomeratesFinance Sonas Holdco ApS functions as an investment holding Danish company. The private company is based in Soborg, Denmark and has subsidiaries in Denmark. The company was founded in 2020. Jeppe Ragnar Andersen has been the CEO of the company since 2020. | Finance |